“However, the elimination of quinupristin derivatives in patients with renal impairment tended to be decreased: mean … drug concentration (Cmax) and area under the concentration-time curve from zero to infinity (AUC∞) of quinupristin … active derivatives were about 1.4 times higher in … with renal impairment compared with healthy volunteers.”